Item 2.02. Results of Operations and Financial Condition.

On May 5, 2008, Vion Pharmaceuticals, Inc. (the “Registrant”) issued a press release reporting its financial results for the three-month period ended March 31, 2008.

A copy of that press release is attached hereto as Exhibit 99.1 and is being furnished to the Securities and Exchange Commission pursuant to this Item 2.02 of Form 8-K.

On May 6, 2008, the Registrant also announced that it would hold a conference call on Thursday, May 8, 2008 at 8:30 a.m. Eastern Time to discuss its 2008 first quarter financial results.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits

 

Exhibit Number

 

Description

99.1

 

Press release dated May 5, 2008.

 

 

-2-

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

VION PHARMACEUTICALS, INC.


Date: May 6, 2008

 

By: 


/s/ Howard B. Johnson

 

 

 

Name: Howard B. Johnson

 

 

 

Title: President and Chief Financial Officer

 

 

-3-

 


EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press release dated May 5, 2008.

 

 

-4-